Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Charles Lapp
(section)
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Notable studies== *1997, Management of Chronic Fatigue Syndrome in Children: A Practicing Clinician's Approach<ref>Charles W. Lapp. (1997). Management of Chronic Fatigue Syndrome in Children: A Practicing Clinician's Approach. ''Journal of Chronic Fatigue Syndrome,'' Vol. 3, Iss. 2, pp 59-76. http://dx.doi.org/10.1300/J092v03n02_07</ref> *1998, Downregulation of RNase L inhibitor correlates with upregulation of interferon-induced proteins (2-5A synthetase and RNase L) in patients with chronic fatigue immune dysfunction syndrome.<ref name="Vojdani, 1998" /> *1999, The Relationship Between Chronic Fatigue Syndrome and Chemical Exposure<ref>Aristo Vojdani & Charles W. Lapp. (1999). The Relationship Between Chronic Fatigue Syndrome and Chemical Exposure. ''Journal of Chronic Fatigue Syndrome'', Vol. 5, Iss. 3-4, pp. 207-221. http://dx.doi.org/10.1300/J092v05n03_18</ref> *2006, Recognizing Pediatric CFS in the Primary Care Practice: A Practicing Clinician's Approach<ref>Charles W. Lapp. (2006). Recognizing Pediatric CFS in the Primary Care Practice: A Practicing Clinician's Approach. ''Journal of Chronic Fatigue Syndrome'', Vol. 13, Iss. 2-3, pp. 89-96. http://dx.doi.org/10.1300/J092v13n02_06</ref> *2007, Defining the Occurrence and Influence of Alpha-Delta Sleep in [[Chronic Fatigue Syndrome]]<ref name="Van Hoof, 2007" /> [https://www.ncbi.nlm.nih.gov/pubmed/17301585 (Abstract)] *2009, Severe versus Moderate criteria for the new [[pediatric]] case definition for [[ME/CFS]]<ref name="Jason, Dec2009" /> [https://www.ncbi.nlm.nih.gov/pubmed/19513826 (Abstract)] *2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist [[rintatolimod]] in severe cases of chronic fatigue syndrome<ref name="Strayer, 2012" /> [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0031334 (Full Text)] *2014, No association found between the detection of either [[xenotropic murine leukemia virus-related virus]] or polytropic murine leukemia virus and [[chronic fatigue syndrome]] in a blinded, multi-site, prospective study by the establishment and use of the [[SolveCFS BioBank & Patient Registry|SolveCFS BioBank]]<ref>{{Cite journal | last = Irlbeck | first = David M. | last2 = Vernon | first2 = Suzanne D. | author-link2 = Suzanne Vernon | last3 = McCleary | first3 = K. Kimberly | author-link3 = Kim McCleary | last4 = Bateman | first4 = Lucinda | author-link4 = Lucinda Bateman | last5 = Klimas | first5 = Nancy G. | author-link5 = Nancy Klimas | last6 = Lapp | first6 = Charles W. | author-link6 = Charles Lapp | last7 = Peterson | first7 = Daniel L. | author-link7 = Daniel Peterson | last8 = Brown | first8 = James R. | last9 = Remlinger | first9 = Katja S.| date = 2014 | title = No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank | url =https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/ | journal = BMC Research Notes | volume = 7 | pages = 461|doi=10.1186/1756-0500-7-461|via= | last10 = Wilfret | last11 = Gerondelis | first11 = Peter | first10 = David A.}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/ (Full Text)] *2016, [[CDC]] Grand Rounds: [[Chronic Fatigue Syndrome]] β Advancing Research and Clinical Education. Morbidity and [[Mortality]] Weekly Report<ref>{{Cite journal | last1 = Unger | first1 = ER | authorlink = Elizabeth Unger | last2 = Lin | first2 = JS | author-link2 = Jin-Mann Sally Lin | last3 = Brimmer | first3 = DJ | author-link3 = | last4 = Lapp | first4 = CW | author-link4 = Charles Lapp | last5 = Komaroff | first5 = AL | author-link5 = Anthony Komaroff | last6 = Nath | first6 = A | author-link6 = Avindra Nath | last7 = Laird | first7 = S | author-link7 = | last8 = Iskander | first8 = J | author-link8 = John Iskander | title = CDC Grand Rounds: Chronic Fatigue Syndrome β Advancing Research and Clinical Education | journal = Morbidity and Mortality Weekly Report | volume = 65 | issue = 5051| page=1434β1438 | date = 2016 | doi=10.15585/mmwr.mm655051a4}} - </ref> - [https://www.cdc.gov/mmwr/volumes/65/wr/mm655051a4.htm (Full Text)] *2017, Multi-Site Clinical Assessment of [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565838/ (Full Text)] *2019, Initiating care of a patient with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref>{{Cite journal | last = Lapp | first = Charles W. | authorlink = Charles Lapp | date = Jan 2019 | title = Initiating Care Of A Patient With Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) | url = https://www.frontiersin.org/articles/10.3389/fped.2018.00415/abstract | journal = Frontiers in Pediatrics | volume = | issue = | pages = |doi=10.3389/fped.2018.00415|quote=|via=}}</ref> [https://www.frontiersin.org/articles/10.3389/fped.2018.00415/full (Full text)] *2019, Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning<ref>{{Cite journal | last = Proskauer | first = Charmian | authorlink = Charmian Proskauer | last2 = Rowe | first2 = Peter C. | author-link2 = Peter Rowe | last3 = Lapp | first3 = Charles W. | author-link3 = Charles Lapp | last4 = DeMaria | first4 = Alfred Jr | author-link4 = | last5 = Bateman | first5 = Lucinda | author-link5 = Lucinda Bateman | last6 = Attewell | first6 = John R. | last7 = Proskauer | first7 = Daniel | last8 = Kiernicki | first8 = David J. | last9 = Adebayo | first9 = Seyi | date = 2019 | title=Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning | url =https://www.frontiersin.org/articles/10.3389/fped.2018.00412/full | journal = Frontiers in Pediatrics|language=English | volume = 6 | issue = | pages = |doi=10.3389/fped.2018.00412|issn=2296-2360|pmc=|pmid=30671425|quote=|via=}}</ref> [https://www.frontiersin.org/articles/10.3389/fped.2018.00412/full (Full text)]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs